Literature DB >> 27753073

Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages.

Jan Klocke1, Katharina Kopetschke2, Anna-Sophie Grießbach2, Valerie Langhans2, Jens Y Humrich3, Robert Biesen2, Duska Dragun2, Andreas Radbruch4, Gerd-Rüdiger Burmester2, Gabriela Riemekasten3, Philipp Enghard1.   

Abstract

Renal infiltration of inflammatory cells contributes to the pathogenesis of lupus nephritis (LN). Current knowledge on the recruitment mechanisms relies mainly on findings in rodent models. Here, we assess various chemokine pathways in human LN by comparing urinary chemokine concentrations (in 25 patients with acute LN and in 78 lupus patients without active LN) with the expression of corresponding chemokine receptors on urinary leukocytes (in ten acute LN patients). Nine urinary chemokines were significantly elevated in LN patients and correlated with renal disease activity and urinary cell counts; however, their concentrations displayed considerable interindividual heterogeneity. Analysis of the corresponding receptors revealed abundance of urinary CD8+ T cells for CCR5 and CXCR3, while CD4+ T cells were additionally enriched for CCR1, CCR6 and CXCR6. Urinary Treg showed similar CCR expression, and urinary CD14+ macrophages were enriched for CCR5 expressing cells. In conclusion, cell specific recruitment patterns seem to involve CCR5 and CXCR3 in all cells studied, while CD4+ T-cell subset recruitment is probably much more varied. However, urinary chemokine abundance in active LN is individually variable in our cohort and does not offer a singular chemokine usable as universal biomarker or potential future treatment target.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biological markers; Chemokines; Lupus nephritis; Systemic lupus erythematosus (SLE); T-Lymphocytes; Urinary chemokines

Mesh:

Substances:

Year:  2016        PMID: 27753073     DOI: 10.1002/eji.201646387

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Glomerular Expression of S100A8 in Lupus Nephritis: An Integrated Bioinformatics Analysis.

Authors:  Wei Qijiao; Chen Zhihan; Panashe Makota; Yan Qing; Gao Fei; Wang Zhihong; Lin He
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

2.  Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis.

Authors:  Andrea Fava; Jill Buyon; Chandra Mohan; Ting Zhang; H Michael Belmont; Peter Izmirly; Robert Clancy; Jose Monroy Trujillo; Derek Fine; Yuji Zhang; Laurence Magder; Deepak A Rao; Arnon Arazi; Celine C Berthier; Anne Davidson; Betty Diamond; Nir Hacohen; David Wofsy; William Apruzzese; Soumya Raychaudhuri; Michelle Petri
Journal:  JCI Insight       Date:  2020-06-18

3.  Facilitated expansion of Th17 cells in lupus nephritis patients.

Authors:  B Jakiela; J Kosałka; H Plutecka; S Bazan-Socha; M Sanak; J Musiał
Journal:  Clin Exp Immunol       Date:  2018-09-23       Impact factor: 4.330

4.  Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis.

Authors:  Jihye Kim; Jung Sun Lee; Heounjeong Go; Joon Seo Lim; Ji Seon Oh; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo; Seokchan Hong
Journal:  Arthritis Res Ther       Date:  2020-07-17       Impact factor: 5.156

5.  ALW peptide ameliorates lupus nephritis in MRL/lpr mice.

Authors:  Huixia Wang; Mei Lu; Siyue Zhai; Kunyi Wu; Lingling Peng; Jie Yang; Yumin Xia
Journal:  Arthritis Res Ther       Date:  2019-12-02       Impact factor: 5.156

6.  New biomarkers in SLE: from bench to bedside.

Authors:  Riccardo Capecchi; Ilaria Puxeddu; Federico Pratesi; Paola Migliorini
Journal:  Rheumatology (Oxford)       Date:  2020-12-05       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.